$CDIO News

Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript

Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript

Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City

Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026

Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans

Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks

Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection

Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians

Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network

Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI

Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine

Cardio Diagnostics Holdings (CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs

Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection

Cardio Diagnostics Holdings (CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences

Cardio Diagnostics Holdings (CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings (CDIO) Focused on Vision for Personalized Heart Care

Cardio Diagnostics Hldgs Q1 EPS $(0.63) Up From $(0.97) YoY, Sales $2.680K Up From $940.000 YoY

Cardio Diagnostics Holdings (CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights